CIK 0001069899 · Large accelerated filer
PHIBRO ANIMAL HEALTH CORP
Sign in to watch- Ticker
- PAHC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 131840497
- Phone
- 201-329-7300
- Business address
- GLENPOINTE CENTRE EAST, 3RD FLOOR, 300 FRANK W. BURR BLVD., SUITE 21, TEANECK, NJ, 07666
- Former names
- PHILIPP BROTHERS CHEMICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-03 | BENDHEIM JACK President and CEO | Conversion 10b5-1 | +30,000 | 56,800 | ||
| 2025-12-03 | BENDHEIM JACK President and CEO | Sale 10b5-1 | −3,520 | $40.77 | $144K | 53,280 |
| 2025-12-03 | BENDHEIM JACK President and CEO | Conversion · Class B Common Stock 10b5-1 | −30,000 | 19,961,034 | ||
| 2025-12-01 | BENDHEIM JACK President and CEO | Sale 10b5-1 | −3,520 | $41.66 | $147K | 26,800 |
| 2025-11-28 | BENDHEIM JACK President and CEO | Sale 10b5-1 | −3,520 | $42.54 | $150K | 30,320 |
| 2025-11-26 | BENDHEIM JACK President and CEO | Sale 10b5-1 | −5,280 | $44.02 | $232K | 33,840 |
| 2025-11-25 | BENDHEIM JACK President and CEO | Sale 10b5-1 | −7,040 | $43.93 | $309K | 39,120 |
| 2025-11-20 | BENDHEIM JACK President and CEO | Sale 10b5-1 | −3,459 | $41.75 | $144K | 46,221 |
| 2025-11-20 | BENDHEIM JACK President and CEO | Sale 10b5-1 | −61 | $42.32 | $3K | 46,160 |
| 2025-11-18 | BENDHEIM JACK President and CEO | Sale 10b5-1 | −5,260 | $43.82 | $230K | 49,700 |
| 2025-11-18 | BENDHEIM JACK President and CEO | Sale 10b5-1 | −20 | $44.28 | $886 | 49,680 |
| 2025-11-17 | BENDHEIM JACK President and CEO | Sale 10b5-1 | −5,280 | $44.56 | $235K | 54,960 |
| 2025-11-14 | BENDHEIM JACK President and CEO | Conversion 10b5-1 | +55,000 | 60,240 | ||
| 2025-11-14 | BENDHEIM JACK President and CEO | Conversion · Class B Common Stock 10b5-1 | −55,000 | 19,991,034 | ||
| 2025-11-13 | BENDHEIM JACK President and CEO | Sale 10b5-1 | −7,147 | $44.37 | $317K | 6,894 |
| 2025-11-13 | BENDHEIM JACK President and CEO | Sale 10b5-1 | −1,654 | $44.93 | $74K | 5,240 |
| 2025-11-12 | BENDHEIM JACK President and CEO | Sale 10b5-1 | −21,536 | $45.23 | $974K | 14,041 |
| 2025-11-11 | BENDHEIM JACK President and CEO | Conversion 10b5-1 | +15,000 | 35,577 | ||
| 2025-11-11 | BENDHEIM JACK President and CEO | Conversion · Class B Common Stock 10b5-1 | −15,000 | 20,046,034 | ||
| 2025-11-10 | BENDHEIM JACK President and CEO | Sale 10b5-1 | −4,124 | $44.00 | $181K | 54,756 |
Page 7 of 18 · 343 trades